Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

Dollars and Sense of Alzheimer's

MP3 WAV

  • If you could spend a small amount now to save billions of dollars later, would you do it? That's what the Alzheimer's Foundation is proposing. Its focus is on five years. By delaying the onset of Alzheimer's by just five years, we'd save hundreds of billions in healthcare.

    The foundation's recent report suggests that by investing two billion dollars a year starting in 2015, the savings of successfully delaying Alzheimer's would pay for the cost of research in just three years. How? Because treating Alzheimer's is expensive.

    Today it costs Medicare $154 billion dollars - that's twenty percent of their entire budget. By 2050, the total cost will skyrocket past one trillion dollars. If, however, a new treatment by 2035 delayed the onset of Alzheimer's by five years, almost six million people would not develop Alzheimer's by 2050. That's a savings of nearly $90 billion for families and $370 billion for the federal government.

    Here's another sobering fact. The proportion of those with early and moderate versus severe stages of the disease will shift to the right by 2050. What does that mean? Well, in the early stages people function well and the financial impact is low. In the moderate stage, memory lapses and confusion become apparent. Then in the final, severe stage, people need extensive daily care. This stage will hit half of all Alzheimer's cases in 2050.

    The impact could be devastating unless an investment is made now. Several studies have the potential to make the five year delay a reality. Even though President Obama has pledged $100 million dollars a year, it's a mere start. We need much much more.

More Information

Changing the Trajectory of Alzheimer's Disease
The report from the Alzheimer's Association regarding the impact of funding a five-year delay in Alzheimer's

Alzheimer's Disease Fact Sheet
From the NIH National Institute for Aging

Overwhelming burden, cost of Alzheimer's to triple, report says
From CNN

Two individuals wearing headphones stand in a recording booth, speaking into microphones with a music stand holding printed pages between them.

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.